Related Experiment Videos
Segmental jumping translocation in leukemia and lymphoma with a highly complex karyotype
1Department of Cancer Cytogenetics, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan.
Leukemia & Lymphoma
|June 27, 1998
Summary
Segmental jumping translocations (SJTs) were identified in leukemia and lymphoma patients, revealing a new mechanism for gene amplification. These chromosomal abnormalities may drive malignant transformation and disease progression.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Malignant transformation in leukemia and lymphoma involves complex genetic alterations.
- Identifying oncogenes driving these transformations is crucial for understanding disease progression.
Purpose of the Study:
- To identify oncogenes associated with malignant transformation in leukemia and lymphoma.
- To characterize a novel type of chromosomal translocation termed "segmental jumping translocation" (SJT).
Main Methods:
- Fluorescence in situ hybridization (FISH) was used to analyze chromosomal abnormalities in 141 leukemia and malignant lymphoma patients.
- Specific chromosomal regions and their involvement in SJTs were identified.
Main Results:
- Segmental jumping translocations (SJTs) were observed in multiple chromosomal regions, including 8q24, 9q34, 11q13, 11q23, 13q14, 14q24-q32, 21q22, and 22q11.
- SJT involving the ABL oncogene at 9q34 was found in secondary leukemia patients.
- Multiple copies of SJTs at 11q13 or 11q23 were detected in Non-Hodgkin's lymphoma and acute myeloid leukemia (AML).
- SJTs at 14q32 and 21q22 were prevalent in adult T-cell leukemia and AML, respectively.
Conclusions:
- SJTs represent a new mechanism for gene amplification and the formation of marker chromosomes in advanced cancers.
- The identified SJTs may harbor oncogenes crucial for the progression of leukemia and lymphoma.
- Further investigation into SJTs can elucidate pathways of malignant transformation.